Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 19, 2003European Journal Of Haematology

Mycophenolate mofetil (MMF) for the treatment of steroid‐resistant idiopathic thrombocytopenic purpura

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMing HouShandong UniversityJPJun PengChinese Academy of Tropical Agricultural SciencesYSYan ShiJiangnan University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hou et al. (2003) studied this question.

synapsesocial.com/papers/6a1b74cb950e49a3ca0c64achttps://doi.org/10.1034/j.1600-0609.2003.00076.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies1987 · 905 citations
  2. 2Mycophenolate mofetil for the treatment of refractory auto‐immune haemolytic anaemia and auto‐immune thrombocytopenia purpura2002 · 153 citations
  3. 3Immune Thrombocytopenic Purpura2002 · 1,348 citations
  4. 4Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity1996 · 363 citations
  5. 5Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn’s disease1999 · 202 citations